B. Sureshbabu et al. / Journal of Organometallic Chemistry 799-800 (2015) 232e238
237
Table 3
7.36 (t, 1H, J ¼ 8 Hz), 6.89e6.92 (t, 2H, J ¼ 8 Hz), 4.06 (s, 3H), 2.80 (s,
3H), 2.79 (s, 3H). 13C NMR (100 MHz, CDCl3, 25 ꢀC):
27.3, 27.4, 37.6,
SuzukieMiyaura reactions of aryl halides with phenylboronic acid using 5 as cata-
d
lyst.a
122.4, 122.5, 126.3, 127.3, 128.7, 128.9, 130.2, 130.2, 131.1, 137.8,
139.6, 144.5, 159.4, 159.8; IR (KBr, cmꢁ1): 3050, 2977, 2917, 2356,
1624, 1472, 1318, 1164,793, 698; HRMS: [MþꢁI] m/z calcd for
C
22H22N4PdI 574.9924, found 574.9933.
Complex 7: 168 mg, 89%; mp.230 ꢀC.1H NMR (400 MHz, CDCl3,
Entry
Aryl halide (R)
Time (h)
Yield (%)b
25 ꢀC):
d
8.58e8.60 (m, 2H), 8.44e8.47 (m, 2H), 8.0e8.02 (m, 2H),
7.56e7.65 (m, 6H), 6.99e7.01 (d, 2H, J ¼ 8.0 Hz), 4.06 (s, 3H), 2.29 (s,
3H); 13C NMR (100 MHz, CDCl3, 25 ꢀC):
21.1, 37.8, 125.3, 125.7,
1
2
3
4
5
6
7
8
9
10
4-bromoanisole
2-bromoanisole
2.5
2.5
3.5
8
3
6
95
92
92
89
99c
93
38
0
d
4-bromobenzoic acid
2-bromobenzoic acid
1,4-dibromobenzene
1,3,5-tribromobenzene
2-chloropyridine
4-chlorotoluene
4-chlorobenzaldehyde
4-trifluoromethyl-chlorobenzene
127.5, 128.8, 129.0, 130.2, 130.8, 139.9, 144.4, 149.2, 153.2; IR (KBr,
cmꢁ1): 3050, 2927, 2850, 1620, 1494, 1333, 1066, 810, 761. HRMS:
[MþꢁI] m/zcalcd for C21H20N4PdI 560.9767, found 560.9791.
Complex 8: 178 mg, 91%; mp.240e245 ꢀC.1H NMR (400 MHz,
8
CDCl3, 25 ꢀC):
d
8.79 (d, 1H, J ¼ 4 Hz), 8.71 (d, 1H, J ¼ 4 Hz), 8.41 (d,
24
24
24
0
0
2H, J ¼ 8 Hz), 7.98 (d, 2H, J ¼ 8 Hz), 7.57e7.66 (m, 7H), 7.13e7.17 (m,
13
1H), 4.06 (s, 3H); C NMR (100 MHz, CDCl3, 25 ꢀC):
d 37.8, 124.6,
a
Reaction conditions: Aryl halide (1 equiv), phenylboronic acid (1.2 equiv),
125.7, 127.3, 128.9, 129.0, 130.3, 130.7, 132.1, 134.1, 137.5, 138.5, 139.7,
144.3, 151.9, 152.8; IR (KBr, cmꢁ1): 3078, 2921, 2850, 2366, 1596,
1462, 1066, 761, 691; HRMS: [MþꢁI] m/zcalcd for C20H17ClN4PdI
580.9221, found 580.9226.
palladium complex 5 (1 mol%), t-BuOK (1.5 equiv) in EtOH at rt.
b
Isolated yields.
p-terphenyl is the product.
c
(TLC) analysis, E-Merck pre-coated TLC plates (silica gel 60 F254
grade, 0.25 mm) were used.
4.2.3. Synthesis of complex 9
A mixture of 1,2,3-triazolim salt iodide 1a (100 mg, 0.28 mmol)
and KCl (81 mg,1.1 mmol) in CH2Cl2 stirred at room temperature for
1 h. Then Pd(OAc)2 (67 mg, 0.30 mmol) was added. The reaction
mixture stirred at room temperature for 15 h. The mixture was
filtered and evaporates the solvent to give crude product. The crude
product dissolved in acetone and evaporates the solvent to give
greenish yellow product. Complex 9 has been reported from our
laboratory [16] and its characterization data are given in the SI.
4.2. Synthesis and characterization
4.2.1. General procedure for the preparation of mononuclear
palladium(II) diiodo NHC complexes (2aec)
A mixture of Pd(OAc)2 (0.6 equiv) and (n-Bu)4NI (1 equiv) in
dichloromethane (20 mL) was stirred at room temperature under
N2 atmosphere for 2 h to give a dark brown to black colour solution.
1,2,3-Triazolium salt iodide (1aec) (100 mg, 1 equiv) was added to
the mixture and stirring was continued for 8e12 h depending upon
the substrate to give orange or light yellow solution. Evaporation of
solvent gave a gummy product. The product was purified by col-
umn chromatography on silica gel using CH2Cl2: MeOH (9:1) as
eluent. Complexes 2aec were reported from our laboratory [12]
and their characterization data are given in the SI.
4.2.4. General procedure for the synthesis of bridged binuclear
complexes
A mixture of triazolium iodide 1a (100 mg, 0.27 mmol),
Pd(OAc)2 (67 mg, 0.3 mmol), KI (91 mg, 0.55 mmol), bridging ligand
(0.16 mmol, 0.6 equiv.) in dichloromethane gave a dark brown so-
lution which was stirred at room temperature for16 h (11 and 12)
and 3 d (10). During this period the dark brown colour changed to
dark orange. The reaction mixture was filtered and solid was
washed with CH2Cl2. The filtrate was evaporated to give the crude
product which was purified by washing with hexane and ether to
give the desired complexes as yellow solids.
4.2.2. General procedure for the synthesis of PEPPSI type complexes
A mixture of triazolium iodide 1a (100 mg, 0.27 mmol),
Pd(OAc)2 (67 mg, 0.3 mmol), KI (180 mg, 1.1 mmol) in dichloro-
methane gave a dark brown solution which was allowed to stir at
room temperature for 16 h. The reaction mixture was filtered and
solvent was evaporated to give binuclear complex 3 in 95% of yield.
In a one pot synthesis pyridine derivative (0.26 mmol, 2 equiv.) in
CH2Cl2 was directly added dropwise to the above reaction mixture.
Upon addition of pyridine derivatives the colour of the reaction
mixture changed from dark brown to dark yellow instantaneously.
The reaction mixture was stirred at room temperature for 12 h (5, 7,
and 8) and 2 d (6), respectively. Evaporation of the solvent gave the
crude product which was purified by washing with hexane and
ether to give PEPPSI type complexes as dark orange or yellow
crystalline solids.
Complex 10: 165 mg, 86%; 1H NMR (400 MHz, CDCl3, 25 ꢀC):
d
8.91 (d, 4H, J ¼ 8 Hz), 8.42 (d, 4H, J ¼ 8 Hz), 7.98e8.0 (m, 4H),
7.57e7.65 (m, 12H), 7.32 (d, 4H), 4.07 (s, 6H). 13C NMR (100 MHz,
CDCl3, 25 ꢀC):
d 37.8, 122.0, 125.7, 127.3, 128.9, 129.0, 130.3, 130.8,
134.8, 139.8, 144.4, 145.7, 154.7; IR (KBr, cmꢁ1): 3057, 2927, 2846,
2356, 1603, 1494, 1329, 1269, 1178, 1073, 1020,765, 694; HRMS:
[Mþ1] m/zcalcd for C40H35N8Pd2I4 1346.7233, found 1346.7232.
Complex 11: 160 mg, 92%; 1H NMR (400 MHz, CDCl3, 25 ꢀC):
d
8.84 (s, 4H), 8.31 (d, 4H, J ¼ 8 Hz), 7.90 (d, 4H, J ¼ 8 Hz), 7.56e7.62
(m, 12H), 4.04 (s, 6H); 13C NMR (100 MHz, CDCl3, 25 ꢀC):
d
37.9,
125.7, 127.0, 128.9, 129.1, 130.4, 130.7, 139.5, 144.2, 149.2; IR (KBr,
cmꢁ1): 3050, 2921, 2846, 1596, 1476, 1455, 1420, 1333, 1185, 1069,
1020,771, 694; HRMS: [MþNa] m/zcalcd for C34H30N8Pd2I4Na
1292.6740, found 1292.6735.
Complex 5: 170 mg, 92%, mp.225 ꢀC.1H NMR (500 MHz, CDCl3,
25 ꢀC):
d
8.76e8.78 (m, 2H), 8.44e8.46 (m, 2H), 8.0e8.02 (m, 2H),
7.56e7.65 (m, 7H), 7.17e7.20 (t, 2H), 4.06 (s, 3H); 13C NMR
Complex 12: 162 mg, 92%; 1H NMR (400 MHz, CDCl3, 25 ꢀC):
(125 MHz, CDCl3, 25 ꢀC):
d
37.8, 124.3, 125.7, 127.4, 128.8, 129.0,
d
8.32 (d, 4H, J ¼ 4 Hz), 7.89 (d, 4H, J ¼ 8 Hz), 7.54e7.57 (m, 12H),
130.2, 130.8, 135.5, 137.3, 139.8, 144.4, 153.9; IR (KBr, cmꢁ1): 3072,
3.99 (s, 6H), 3.30 (s, 12H); 13C NMR (100 MHz, CDCl3, 25 ꢀC):
d
29.8,
2976, 2840, 1615, 1550, 1490, 790, 692; HRMS: [MþꢁI] m/z calcd for
37.8, 54.1, 125.5, 127.2, 127.7, 128.7, 128.8, 130.2, 130.2, 130.6, 139.6,
143.7; IR (KBr, cmꢁ1): 3057, 2927, 2850, 1592, 1490, 1464, 1329,
1269, 1182, 793, 758; HRMS: [Mþ1] m/zcalcd for C36H39N8Pd2I4
1302.7546, found 1302.7543.
C
20H18N4 PdI 546.9611, found 546.9630.
Complex 6: 159 mg, 82%; mp.255 ꢀC.1H NMR (400 MHz, CDCl3,
25 ꢀC):
d 8.31e8.34 (m, 2H), 7.97e8.0 (m, 2H), 7.56e7.64 (m, 6H),